Related Experiment Video
Updated: Aug 13, 2026

The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
Biostatistical assessment of mutagenicity studies by including the positive control
Dieter Hauschke1, Renate Slacik-Erben, Sabrina Hensen
1Department of Biometry, Altana Pharma, Germany. dieter.hauschke@altanapharma.com
Abstract:
Statistical analysis plays a fundamental part in the evaluation of mutagenicity experiments. However, a statistically significant or non-significant test result without incorporating the biological relevance cannot be a valid scientific criterion for concluding a positive or negative effect of the underlying compound (Hauschke et al., 1997). The classification of an experiment as being negative or positive should be based also on the magnitude of the responses in the positive control. We address the problem of determining the maximum safe dose by incorporating a biologically meaningful threshold value, which is expressed as a fraction of the difference between positive and vehicle control.
Related Concept Videos
Mutagenicity and Carcinogenicity
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
In vitro Mutagenesis

